Parkin disease and the Lewy body conundrum

Authors

  • Karen M. Doherty MRCP,

    Corresponding author
    1. Reta Lila Weston Institute of Neurological Studies and Research Laboratories, Departments of Molecular Neuroscience and Clinical Neuroscience, University College London Institute of Neurology, London, United Kingdom
    • Correspondence to: Dr. K. M. Doherty, Reta Lila Weston Institute of Neurological Studies, 1 Wakefield Street, London, WC1N 1PJ United Kingdom; k.doherty@ucl.ac.uk

    Search for more papers by this author
  • John Hardy PhD

    1. Reta Lila Weston Institute of Neurological Studies and Research Laboratories, Departments of Molecular Neuroscience and Clinical Neuroscience, University College London Institute of Neurology, London, United Kingdom
    Search for more papers by this author

  • Funding agencies: This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosporylation Unit at the University of Dundee.

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary